| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 640 | $130 | $83.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 890 | $60 | $49.7K |
| J9030 | BCG live intravesical instillation, 1 mg | 11,800 | $1 | $23.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 250 | $80 | $19.3K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 240 | $60 | $14.1K |
| J9155 | Injection, degarelix, 1 mg | 4,080 | $1 | $12.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 60 | $110 | $6.7K |
| 51798 | Providers perform this ultrasound to measure the volume of residual urine in the bladder. | 810 | $10 | $6.5K |
| 96402 | In this procedure, the provider administers chemotherapy either subcutaneously, meaning under the skin, or intramuscularly, meaning in muscle. He administers a hormonal anti–neoplastic drug. | 200 | $20 | $4.1K |
| 82570 | The lab analyst measures the amount of creatinine, in a patient specimen, other than blood. Creatinine is the waste material generated by the muscle tissue produced from the breakdown of creatine… | 720 | $10 | $3.6K |